Akzo Nobel Slips To Q3 Loss On Weak Volume; Sees FY25 Adj. EBITDA Of EUR 1.48 Bln

Akzo Nobel NV reported a Q3 net loss of 194 million euros, reversing a prior-year profit, with revenue declining 5% to 2.55 billion euros due to adverse currencies and lower volumes, despite a 1% organic sales increase. However, the company improved its adjusted EBITDA margin to 15.1% from 14.8% through efficiency measures. Looking ahead, Akzo Nobel projects fiscal 2025 adjusted EBITDA around 1.48 billion euros and targets a mid-term adjusted EBITDA margin above 16%, while its divestment of Akzo Nobel India Ltd. is on track for completion by December 2025.

Analysis

Akzo Nobel NV reported a significant net loss of 194 million euros in Q3, reversing a prior-year profit of 163 million euros, primarily due to a 5% revenue decline to 2.55 billion euros impacted by adverse currencies and lower volumes. Despite this top-line pressure, the company achieved a 1% organic sales increase driven by price/mix improvements.

Crucially, Akzo Nobel demonstrated operational resilience, improving its adjusted EBITDA margin to 15.1% from 14.8% year-over-year. This margin expansion was attributed to efficiency actions and structural cost measures, which partly offset the impact of lower volumes and general inflation. Adjusted EBITDA, however, still saw a slight 2% decline to 385 million euros.

Looking ahead, the company projects fiscal 2025 adjusted EBITDA around 1.48 billion euros, subject to ongoing market uncertainties. Mid-term targets include an adjusted EBITDA margin above 16% and a return on investment between 16% and 19%. The intended divestment of Akzo Nobel India Ltd. is also progressing, with completion expected by December 2025.

The mixed Q3 results highlight a company navigating challenging external conditions with internal operational improvements. While reported earnings were negative, the underlying margin expansion and organic sales growth suggest a degree of fundamental strength, albeit overshadowed by currency headwinds and volume softness.

Key Decisions for Investors

• Monitor the sustainability of margin expansion through efficiency actions against persistent revenue and volume pressures, especially given adverse currency impacts.
• Evaluate the achievability of the fiscal 2025 adjusted EBITDA target of 1.48 billion euros, considering stated market uncertainties and currency volatility.
• Track the successful completion of the Akzo Nobel India Ltd. divestment by December 2025 for potential capital structure and strategic implications.